Innovating Works

SUM

INNODIA HARVEST: Translational approaches to disease modifying therapy of type 1 diabetes HARVESTing the fruits of... SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Building on the strong foundations of INNODIA, with its unique, Europe-wide clinical and basic research network for the study of type 1 diab...
2020-04-16 - 2024-04-30 | Financiado
PROFID: Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardi... SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un H2020: H2020-SC1-BHC-2018-2020 Sudden cardiac death (SCD) is a major public health problem accounting for ~20% of all deaths in Europe with an estimated yearly incidence o...
2019-12-13 - 2024-12-31 | Financiado
ReGenHeart: Clinical development and proof of principle testing of new regenerative VEGF D therapy for cost effe... SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un H2020: H2020-SC1-2016-2017 Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately c...
2016-12-01 - 2022-12-31 | Financiado
OcuTher: Educational Network in Ocular Drug Delivery and Therapeutics SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un H2020: H2020-MSCA-ITN-2016 Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big...
2016-08-16 - 2020-10-31 | Financiado
INNODIA: Translational approaches to disease modifying therapy of type 1 diabetes an innovative approach tow... SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un H2020: H2020-JTI-IMI2-2014-01-two-stage Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findi...
2015-12-07 - 2023-10-31 | Financiado
SCIENCE: Stem Cell therapy in IschEmic Non treatable Cardiac diseasE SCIENCE SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un H2020: H2020-PHC-2014-2015 Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) With more than 17 million deaths worldwide each year, ischemic heart...
2014-12-03 - 2020-12-31 | Financiado
STEPS: STrengthening Engagement in Public health research SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un FP7: Public health is of growing importance to the European Union and its citizens. STEPS is designed to increase civil society organisation part...
Financiado
BAMI: The effect of intracoronary reinfusion of bone marrow derived mononuclear cells BM MNC on all caus... SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un FP7: Although the long term prognosis of patients suffering acute myocardial infarction (AMI) has improved since the introduction of reperfusion...
Financiado
SIRENA: Silesian Researchers NOW! SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un FP7: "This year The Silesian Researchers' Night will embrace five most important and renown Universities from the Silesian Region, covering almos...
Financiado
SIRIUS: Silesian Researchers with us SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un FP7: "The 2011 Researchers' Night coordinated by the Silesian University of Technology (Gliwice, Poland) is actually continuation of 5 previous s...
Financiado
SYSKID: Systems biology towards novel chronic kidney disease diagnosis and treatment SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH participó en un FP7: Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts t...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.